Indian Pharma Network (IPN)
Medicines For Bowel Cancer Treatment
IPN, New Delhi can facilitate Bowel Cancer patient to “import of Medicines For Bowel Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Indian Pharma Network
M: +91-9891296838 / 9811747774
Bowel Cancer Treatment
Bowel cancer treatment can vary depending on the stage and other characteristics of the cancer. Here are some of the medications that may be used to treat bowel cancer:
Get Access FDA Approved Medicines For Bowel Cancer Treatment
Chemotherapy is often used as part of the treatment plan for bowel cancer, both before and after surgery. The specific medications used may vary depending on the stage of the cancer, the patient’s overall health, and other individual factors. Here are some of the most commonly used chemotherapy medications for bowel cancer treatment:
- 5-fluorouracil (5-FU):
This drug has been used for many years to treat bowel cancer. It interferes with the production of DNA in cancer cells, slowing their growth and preventing them from dividing.
This medication is similar to 5-FU and works in a similar way, but it is taken orally rather than given by injection.
This drug is often given in combination with 5-FU or capecitabine. It damages the DNA in cancer cells and can be effective in slowing or stopping their growth.
This medication is often used in combination with 5-FU or capecitabine. It interferes with the cell division process in cancer cells, causing them to die.
This medication is a type of targeted therapy that blocks the formation of new blood vessels in tumors, which can slow or stop their growth.
It’s important to note that chemotherapy medications can have side effects, and the specific side effects can vary depending on the drug. Common side effects may include nausea, vomiting, diarrhea, fatigue, and hair loss. Your doctor will discuss the potential benefits and risks of chemotherapy with you before starting treatment.
Targeted therapies are a type of cancer treatment that specifically target certain proteins or molecules that are involved in the growth and spread of cancer cells. Here are some of the targeted therapy medications that may be used in the treatment of bowel cancer:
This medication targets a protein called epidermal growth factor receptor (EGFR), which is found on the surface of some cancer cells. By blocking EGFR, cetuximab can slow or stop the growth of cancer cells.
Similar to cetuximab, panitumumab targets the EGFR protein.
This medication targets multiple proteins involved in the growth and spread of cancer cells. It is often used in patients with advanced bowel cancer that has not responded to other treatments.
As mentioned earlier, this medication can be used as a targeted therapy by blocking the formation of new blood vessels in tumors, which can slow or stop their growth.
This medication targets a protein called vascular endothelial growth factor receptor 2 (VEGFR2), which is involved in the growth of blood vessels that supply nutrients to tumors. By blocking VEGFR2, ramucirumab can help slow or stop the growth of cancer cells.
Like chemotherapy, targeted therapy medications can have side effects, which may vary depending on the drug. Common side effects may include rash, diarrhea, high blood pressure, and fatigue. Your doctor will discuss the potential benefits and risks of targeted therapy with you before starting treatment.
Immunotherapy is a type of cancer treatment that uses drugs to help the body’s own immune system to fight cancer. Here are some of the immunotherapy medications that may be used in the treatment of bowel cancer:
This medication is a type of checkpoint inhibitor, which blocks a protein called PD-1 that is found on certain immune cells. By blocking PD-1, pembrolizumab can help the immune system recognize and attack cancer cells.
Similar to pembrolizumab, nivolumab is a checkpoint inhibitor that targets the PD-1 protein.
This medication targets a protein called PD-L1, which is found on some cancer cells. By blocking PD-L1, atezolizumab can help the immune system recognize and attack cancer cells.
This medication targets a protein called CTLA-4, which is found on certain immune cells. By blocking CTLA-4, ipilimumab can help activate the immune system to attack cancer cells.
This medication is also a checkpoint inhibitor that targets the PD-L1 protein.
Immunotherapy medications can have side effects, which may vary depending on the drug. Common side effects may include fatigue, diarrhea, rash, and changes in the thyroid gland function. Your doctor will discuss the potential benefits and risks of immunotherapy with you before starting treatment.
Radiation therapy uses high-energy radiation to kill cancer cells. It may be used in combination with chemotherapy or surgery for locally advanced bowel cancer.
It’s important to note that treatment plans for bowel cancer are highly individualized, and the medications and treatments used will depend on the specific characteristics of the cancer and the individual patient’s needs. It’s best to consult with a healthcare provider to determine the most appropriate treatment plan for your specific case.
Legitimate Healthcare Consultant and Facilitator In Delhi
If you have a question relating to anti-cancer medicines approved for treatment of Bowel Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email firstname.lastname@example.org as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
Query Form For Medications
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa